Latest FDA news on anemia drugs

From the Wall Street Journal article:

A Food and Drug Administration advisory committee stopped short of supporting a clear-cut new limit on kidney-failure patients' use of the blockbuster anemia drugs made by Amgen Inc. and Johnson & Johnson, but members split over what doses of the medications are appropriate.

Click here to access (sub. req.).